CVR: 41349751
WeCure Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020 and dissolved in 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2022, the company reported a gross profit of DKK 15,442 and a net result of DKK 11,742 compared with DKK 3,875 the year before. Equity amounted to DKK 48,745.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
As of May 14, 2024, Henrik Gattermann has stepped down as director of WeCure Pharma Nordic ApS.
As of May 14, 2024, Tomas Ludvigsson has stepped down as director of WeCure Pharma Nordic ApS.
As of May 14, 2024, Per Göran Öberg has stepped down as director of WeCure Pharma Nordic ApS.
WeCure Pharma Nordic ApS was dissolved on May 14, 2024.
WeCure Pharma Nordic ApS has published its annual report for 2022. Gross profit came to DKK 15,442, and the net result was DKK 11,742.
WeCure Pharma Nordic ApS has published its annual report for 2021. Gross profit came to DKK 5,504, and the net result was DKK 3,875.
WeCure Pharma Nordic ApS has published its interim report for the period May 5, 2020 – December 31, 2020.
As of May 5, 2020, Henrik Gattermann is registered as director of WeCure Pharma Nordic ApS.
As of May 5, 2020, Tomas Ludvigsson is registered as director of WeCure Pharma Nordic ApS.
As of May 5, 2020, Per Göran Öberg is registered as director of WeCure Pharma Nordic ApS.
WeCure Pharma Nordic ApS was founded on May 5, 2020.
Companies in the same industry and area
CVR 26785464
CVR 31501296
CVR 26933501
CVR 28982968
CVR 28695780
companydata.dk